| Company Name: |
SPIRO PHARMA |
| Tel: |
|
| Email: |
eric_feng1954@126.com |
PDK1/Akt/Flt Dual Pathway Inhibitor manufacturers
- KP-23172
-
- $1520.00
-
2026-07-27
- CAS:331253-86-2
- Purity:
- Supply Ability: 10g
- KP-23172
-
- $1520.00
-
2026-07-27
- CAS:331253-86-2
- Purity:
- Supply Ability: 10g
- KP-23172
-
- $1520.00
-
2025-08-22
- CAS:331253-86-2
- Purity:
- Supply Ability: 10g
|
| | PDK1/Akt/Flt Dual Pathway Inhibitor Basic information |
| | PDK1/Akt/Flt Dual Pathway Inhibitor Chemical Properties |
| density | 2.01±0.1 g/cm3(Predicted) | | storage temp. | 2-8°C | | solubility | DMSO: 10mg/mL | | pka | -3.05±0.20(Predicted) | | form | solid | | color | yellow | | InChI | 1S/C10H4N6O/c17-9-6-4-2-1-3-5(6)7-8(9)11-10-12-14-15-16(10)13-7/h1-4H | | InChIKey | SSNMLKNJEUSPDY-UHFFFAOYSA-N | | SMILES | [n]21nnnc2nc3c(n1)c4c(cccc4)C3=O |
| Storage Class | 10-13 - German Storage Class 10 to 13 |
| | PDK1/Akt/Flt Dual Pathway Inhibitor Usage And Synthesis |
| Uses | PDK1/Akt/Flt Dual Pathway Inhibitor is a cell-permeable compound that selectively induces apoptosis. | | Biological Activity | Cell permeable: yes', 'Primary Target Both PDK1 and Akt activities', 'Product does not compete with ATP.', 'Reversible: no', 'Target IC50: 1.05, 1.91, and 0.43 μM for AML with wild-type Flt3, single mutant ITD/D835, and double mutant Flt3-ITD-TDK, respectively |
| | PDK1/Akt/Flt Dual Pathway Inhibitor Preparation Products And Raw materials |
|